
Stryker Corp (SYK), a large-cap medical equipment and supplies firm, has garnered an 81% rating from Validea's Multi-Factor Investor model, which is based on Pim van Vliet's low-volatility strategy. This quantitative model targets low volatility stocks exhibiting strong momentum and high net payout yields, with scores exceeding 80% signaling investment interest. While SYK passed market capitalization and standard deviation criteria, it showed neutral performance on momentum and net payout yield, positioning it as a stock of 'some interest' for quantitative, factor-based investors.
Stryker Corp (SYK) has been identified by a Validea quantitative screen based on Pim van Vliet's multi-factor model, which prioritizes low-volatility stocks with strong momentum and high net payout yields. SYK achieved a score of 81%, a level considered to indicate 'some interest' from the strategy. The large-cap medical equipment firm passed the model's criteria for market capitalization and standard deviation, confirming its low-volatility characteristics. However, the analysis reveals neutral performance on two other critical factors: 'Twelve Minus One Momentum' and 'Net Payout Yield'. This mixed assessment is further highlighted by a 'FAIL' on the 'FINAL RANK' test within the detailed criteria table, suggesting that while SYK exhibits a desirable conservative profile, it does not fully align with all drivers of the strategy, namely momentum and shareholder returns.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly positive
Sentiment Score
0.35
Ticker Sentiment